Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04435145 · ClinicalTrials.gov registry record · NA

Warning Labels and College Students' Sugar-Sweetened Beverage Intake

A NA study of Diet, Healthy, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
1,067
Enrollment target
1
Study location

NCT04435145: Completed NA study of Diet, Healthy, sponsored by University of Michigan.

NCT04435145 is a NA study of Diet, Healthy that has completed, run by University of Michigan. The registered enrollment target is 1,067 participants, above the 485-participant average among 48 other Diet, Healthy trials with a reported enrollment target (120% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04435145, a NA study of Diet, Healthy, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
1,067 participants
Enrollment target
1
Study location

Study Summary

Sugar-sweetened beverages (SSBs) are one of the few dietary items causally linked to the development of obesity and chronic disease. SSB consumption among young adults are particularly concerning, because of the high levels of consumption and the influence of disease risk in later life. College students, particularly freshmen, are a captive audience when it comes to dietary consumption because many of them consume their meals in residential dining halls. We are currently working with Michigan Dining to implement warning labels on SSB fountain dispensers to examine whether carefully tailored signage could alter beverage choices of college students. The current study aims to assess changes in dietary intake before and after the labels are posted, in a representative sample of University of Michigan students who eat at residential dining halls.

Primary Outcome

The primary outcome is the mean servings of sugar-sweetened and non-sugar-sweetened beverages consumed in the past 30 days, as measured by a validated questionnaire

Conditions Studied

Interventions

  • BEHAVIORAL Sugar-sweetened beverage warning label

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 1,067 participants
Start Date 2018-11-06
Est. Completion 2019-03-31
Phase NA
University of Michigan

1,327 total trials

What the finished NCT04435145 record still lists

NCT04435145 is an interventional study that assigns participants to a tested intervention. Its 1,067 participants enrollment target places it among the larger protocols in the corpus, above the 485-participant average among 48 other Diet, Healthy trials with a reported enrollment target (120% higher).

The record links to 1 condition, with Diet, Healthy appearing as the primary indexed condition, and to 1 intervention - of which Sugar-sweetened beverage warning label is the first listed.

NCT04435145 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT04435145 about?

NCT04435145 is a clinical study titled "Warning Labels and College Students' Sugar-Sweetened Beverage Intake". Sugar-sweetened beverages (SSBs) are one of the few dietary items causally linked to the development of obesity and chronic disease. SSB consumption among young adults are particularly concerning, because of the high levels of consumption and the influence of disease risk in later life. College stud...

What is the current status of trial NCT04435145?

This trial is currently completed. It is a NA study. The enrollment target is 1,067 participants. The study started on 2018-11-06. Estimated completion is 2019-03-31.

What conditions does trial NCT04435145 study?

This clinical trial studies the following conditions: Diet, Healthy.

What interventions are being tested in trial NCT04435145?

The interventions under investigation include: Sugar-sweetened beverage warning label (BEHAVIORAL).

Who is sponsoring clinical trial NCT04435145?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04435145 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diet, Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04435145's enrollment target sits among peer trials

1,067 7th of 48 higher than 42 of 48 other Diet, Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diet, Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04165798 · 1,065 participants

    KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)

  • NCT06751043 · 1,072 participants · NA

    Preoperative Fasting vs. Not Fasting in Critically Ill Patients

  • NCT06159673 · 1,074 participants · Phase 2

    ACP-204 in Adults With Alzheimer's Disease Psychosis

  • NCT05520762 · 1,060 participants · NA

    Hospital Airway Resuscitation Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04435145, the US trial registry maintained by the National Library of Medicine. NCT04435145 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.